Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Go Naka"'
Autor:
Akinari Tsukada, Chie Morita, Yosuke Shimizu, Yukari Uemura, Go Naka, Jin Takasaki, Hiroshi Nokihara, Shinyu Izumi, Masayuki Hojo
Publikováno v:
Thoracic Cancer, Vol 15, Iss 25, Pp 1854-1862 (2024)
Abstract Background Recent advancements in advanced non‐small‐cell lung cancer (NSCLC) treatment have significantly improved primary therapy outcomes owing to the emergence of various molecular targeted therapies and immune checkpoint inhibitors
Externí odkaz:
https://doaj.org/article/e9686ee606c04e7b85e9be9001db83ce
Autor:
Yuichiro Takeda, Go Naka, Yuki Katsuya, Konomi Kobayashi, Manabu Suzuki, Masao Hashimoto, Satoshi Hirano, Yukari Uemura
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Pemetrexed is an efficacious multi-targeted antifolate with acceptable toxicity for non-squamous non-small cell lung cancer (non-Sq NSCLC) and malignant pleural mesothelioma. Vitamin B12 and folic acid as premedication can reduce
Externí odkaz:
https://doaj.org/article/b54f1d9523c74b46a6c00a96f32e8867
Autor:
Manabu Suzuki, MD, Hiromu Watanabe, MD, Masao Hashimoto, MD, Satoru Ishii, MD, Go Naka, MD, Motoyasu Iikura, MD, Shinyu Izumi, MD, Yuichiro Takeda, MD, Masayuki Hojo, MD, Haruhito Sugiyama, MD
Publikováno v:
Radiology Case Reports, Vol 17, Iss 11, Pp 4232-4238 (2022)
Pulmonary hamartomas are common benign lung tumors; however, endobronchial hamartomas are relatively rare. We report a case of asymptomatic endobronchial hamartoma in a 51-year-old man. Chest computed tomography revealed a 10-mm protrusion in the rig
Externí odkaz:
https://doaj.org/article/ad1aa2d2e1434f4e8ec668a535978aad
Autor:
Akane Ishida, Ayumi Ushio, Masao Hashimoto, Satoru Ishii, Go Naka, Motoyasu Iikura, Shinyu Izumi, Masayuki Hojo, Haruhito Sugiyama
Publikováno v:
Thoracic Cancer, Vol 13, Iss 14, Pp 2075-2077 (2022)
Abstract Docetaxel is a cytotoxic taxane frequently used to treat patients with various cancers, including non‐small cell lung cancer (NSCLC). Docetaxel is known to cause acute myalgias, arthralgias, and neuropathy, but there have been few publishe
Externí odkaz:
https://doaj.org/article/a1d3d3ec82a248158b23efe94d77ce0f
Autor:
Momoko Morishita, Manabu Suzuki, Hiromu Watanabe, Chie Morita, Akane Ishida, Masao Hashimoto, Go Naka, Yuichiro Takeda, Masayuki Hojo, Haruhito Sugiyama
Publikováno v:
Thoracic Cancer, Vol 12, Iss 10, Pp 1613-1616 (2021)
Abstract A 62‐year‐old woman with rheumatoid arthritis and a history of receiving immunosuppressant therapy had a recurrence of lung adenocarcinoma with EGFR L858R mutation. Following 14 months of treatment with erlotinib, computed tomography (CT
Externí odkaz:
https://doaj.org/article/0b1417f52d8a4b5aa0f17f5e18adaf94
Autor:
Yuichiro Takeda, Go Naka, Yoh Yamaguchi, Masao Hashimoto, Manabu Suzuki, Shinyu Izumi, Haruhito Sugiyama
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Osimertinib, a third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI), can be used as second-line treatment for lung cancer patients harboring the T790M substitution. Although osimertinib is more
Externí odkaz:
https://doaj.org/article/f8dbd7f2dce347dd84206d01c7f380d8
Autor:
Yuriko Ueki, Manabu Suzuki, Yuriko Horikawa, Hiromu Watanabe, Yoh Yamaguchi, Chie Morita, Akinari Tsukada, Hiroshi Takumida, Yusaku Kusaba, Takashi Katsuno, Yoshie Tsujimoto, Keita Sakamoto, Masao Hashimoto, Junko Terada, Satoru Ishii, Jin Takasaki, Go Naka, Motoyasu Iikura, Shinyu Izumi, Yuichiro Takeda, Masayuki Hojo, Haruhito Sugiyama
Publikováno v:
Thoracic Cancer, Vol 11, Iss 9, Pp 2731-2735 (2020)
Abstract Immune checkpoint inhibitors (ICIs) are reportedly effective against many kinds of neoplasm, but may be responsible for several kinds of immune‐related adverse events (irAEs). Among these irAEs, the incidence of myelosuppression due to ICI
Externí odkaz:
https://doaj.org/article/25dedb817d3148c69a374d619a8d248d
Autor:
Ryogo Minamimoto, Yuichiro Takeda, Masatoshi Hotta, Jun Toyohara, Kazuhiko Nakajima, Go Naka, Haruhito Sugiyama
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-10 (2019)
Abstract Background 4′-[Methyl-11C] thiothymidine (4DST) PET/CT provides DNA synthesis imaging, which represented a higher correlation with the proliferation in advanced non-small cell lung cancer (NSCLC) than that from imaging with FDG. The aim of
Externí odkaz:
https://doaj.org/article/3ea90fa8af76425ba801d091ad6e9213
Publikováno v:
Respirology Case Reports, Vol 8, Iss 2, Pp n/a-n/a (2020)
Lung cancer immunotherapy is an effective treatment option; however, it can be hampered by adverse events, including pancreatitis, associated with excessive immune activation. Here, we report the case of a 70‐year‐old patient who presented with r
Externí odkaz:
https://doaj.org/article/cb45b2f15cc84bf2884599566c6c00e1
Autor:
Kentaro Tamura, Manabu Suzuki, Satoru Ishii, Jin Takasaki, Go Naka, Motoyasu Iikura, Shinyu Izumi, Yuichiro Takeda, Masayuki Hojo, Haruhito Sugiyama
Publikováno v:
Respiratory Medicine Case Reports, Vol 30, Iss , Pp 101066- (2020)
In general, we have to assume tuberculous pleurisy when a patient presents with pleural effusion and elevated adenosine deaminase (ADA). However, other diseases need to be considered, including immunoglobulin (Ig)G4-related disease (IgG4-RD). This ca
Externí odkaz:
https://doaj.org/article/39f69380d218496abd51a66ee7f1d6f2